Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines

[1]  K. Kashfi,et al.  The mechanism of action of nitric oxide-donating aspirin. , 2007, Biochemical and biophysical research communications.

[2]  D. Amadori,et al.  Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines* , 2006, Apoptosis.

[3]  Anna Tesei,et al.  Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts , 2006, Molecular Cancer Therapeutics.

[4]  Jianjun Gao,et al.  Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Amadori,et al.  Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells , 2005, Apoptosis.

[6]  K. Kashfi,et al.  Molecular targets of nitric-oxide-donating aspirin in cancer. , 2005, Biochemical Society transactions.

[7]  Hani Doss,et al.  Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). , 2005, Oncology reports.

[8]  D. Amadori,et al.  In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines , 2005, Journal of Translational Medicine.

[9]  F. Sinicrope,et al.  Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells. , 2005, Molecular cancer therapeutics.

[10]  Seong-ho Lee,et al.  Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. , 2004, Carcinogenesis.

[11]  M. Takemura,et al.  Non‐steroidal anti‐inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase‐2 protein expression in endometrial cancer cells , 2004, Cancer science.

[12]  Jui‐I Chao,et al.  Down-regulation of Survivin in Nitric Oxide-induced Cell Growth Inhibition and Apoptosis of the Human Lung Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[13]  D. Amadori,et al.  Schedule-Dependent Cytotoxic Interaction between Epidoxorubicin and Gemcitabine in Human Bladder Cancer Cells in Vitro , 2004, Clinical Cancer Research.

[14]  Jianjun Gao,et al.  Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. , 2003, Cancer research.

[15]  G. Chaudhuri,et al.  Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. , 2003, Cancer research.

[16]  J. Wallace,et al.  The therapeutic potential of NO‐NSAIDs , 2003, Fundamental & clinical pharmacology.

[17]  B. Rigas,et al.  NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review). , 2002, International journal of oncology.

[18]  B. Calvo,et al.  Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. , 2002, Gastroenterology.

[19]  A. Hochberg,et al.  Nitric oxide synthase immunoreactivity in human bladder carcinoma , 2001, Molecular pathology : MP.

[20]  U. Engelmann,et al.  Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. , 2001, The Journal of urology.

[21]  F. Traganos,et al.  Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. , 2001, Cancer research.

[22]  S. Baek,et al.  Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. , 2001, Molecular pharmacology.

[23]  D. Seol,et al.  Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells , 2001, Oncogene.

[24]  C. Arrowsmith,et al.  Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression* , 2000, The Journal of Biological Chemistry.

[25]  B. Ames,et al.  Fluorescence detection of 8-oxoguanine in nuclear and mitochondrial DNA of cultured cells using a recombinant Fab and confocal scanning laser microscopy. , 2000, Free radical biology & medicine.

[26]  F. Sinicrope,et al.  Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.

[27]  N. Wiklund,et al.  Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines. , 1999, Urology.

[28]  S. Vukicevic,et al.  Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family* , 1998, The Journal of Biological Chemistry.

[29]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[30]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[31]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.